Antinociceptive synergy between diclofenac and morphine after local injection into the inflamed site.
Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 2
Abstract
Background: Combinations of non-steroidal anti-inflammatory drugs with opioids are frequently used to reduce opioid doses required in the clinical management of acute pain. The present study was designed to evaluate the possible antinociceptive interaction between morphine and diclofenac at peripheral level in male rats. Methods: Drugs were chosen based on their efficacy in the treatment of this kind of pain and as representative drugs of their respective analgesic groups. For the formalin test, 50 μ of 1% formalin solution was injected subcutaneously into the right hind paw. The interaction between morphine and diclofenac was evaluated by using isobolographic analysis and interaction index. Drug interaction was examined by administering fixed-ratio combinations of morphine-diclofenac (1 : 1 and 3 : 1) of their respective ED30 fractions. Results: Diclofenac and morphine reduced flinching behavior in a dose-dependent manner during phase 2 but not phase 1 of the formalin test. Isobolographic analysis showed a synergistic interaction for the combination of morphine and diclofenac after local peripheral administration. Conclusions: Data suggest that the combination of morphine with diclofenac at the site of injury is synergistic and could be useful in the treatment of wounds, bruises, rheumatisms and other painful peripheral conditions associated with an inflammatory process.
Authors and Affiliations
Jorge Torres-López, Elizabeth Carmona-Díaz, José Cortés-Peñaloza, Crystell Guzmán-Priego, Héctor Rocha-González
Keywords
Related Articles
- EP ID EP161836
- DOI -
- Views 101
- Downloads 0
Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems.
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is accepted as one of the fundamental biological mechanisms that underlie major depression. This hyperactivity is caused by diminished feedback inhibition of...
Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y system.
None of the receptor ligands studied: the dopamine D(2) antagonist eticlopride, D(2)/D(3) antagonist haloperidol, alpha(1)-adrenergic antagonist prazosin, N-methyl-D-aspartate antagonist MK-801, 5-HT(2)/D(2) antagonist m...
Epicutaneous immunization with hapten-conjugated protein antigen alleviates contact sensitivity mediated by three different types of effector cells.
Background: Allergic contact dermatitis (ACD) is a common clinical condition in industrialized countries and often causes occupational diseases. Animal model of contact sensitivity (CS) is commonly used to study ACD in m...
Plasma biomarkers of endothelial dysfunction in patients with hypertrophic cardiomyopathy.
Impairment of endothelium-dependent coronary vasodilatation has been reported in hypertrophic cardiomyopathy (HCM). The aim of our study was to evaluate whether HCM patients have increased circulating blood markers of en...
Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein(+) cancers.
Background: P-glycoprotein (P-gp) is expressed on the blood-brain barrier (BBB) and acts as a transporter regulating the analgesic effect of morphine. The P-gp is also expressed by different types of tumors. The aim of t...